Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Stock Falls 0.3% – Time to Sell?

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report)’s stock price traded down 0.3% during mid-day trading on Thursday. The company traded as low as $5.57 and last traded at $5.8050. 485,976 shares traded hands during mid-day trading, an increase of 136% from the average daily volume of 205,918 shares. The stock had previously closed at $5.82.

Health Sciences Acquisitions Co. 2 Price Performance

The company has a 50-day moving average of $5.62 and a 200 day moving average of $4.60.

About Health Sciences Acquisitions Co. 2

(Get Free Report)

Health Sciences Acquisitions Co 2 (NASDAQ:HSAQ) is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with one or more companies in the healthcare and life sciences sectors.

The company does not operate as a traditional healthcare provider, pharmaceutical manufacturer, medical-device developer or biotechnology company. Its activities have primarily involved raising capital through a public offering, evaluating potential acquisition targets and pursuing a merger, stock exchange, asset acquisition, reorganization or similar transaction.

Because Health Sciences Acquisitions Co 2 was established as a blank-check company, information about operating products, commercial services, geographic markets and business leadership is limited unless and until it completes a business combination.

Featured Stories

Receive News & Ratings for Health Sciences Acquisitions Co. 2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and related companies with MarketBeat.com's FREE daily email newsletter.